These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 16390397)

  • 21. Tuberculosis in patients with end-stage renal disease undergoing dialysis in an endemic region of Turkey.
    Sen N; Turunc T; Karatasli M; Sezer S; Demiroglu YZ; Oner Eyuboglu F
    Transplant Proc; 2008; 40(1):81-4. PubMed ID: 18261551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
    Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.
    Singh N; Wagener MM; Gayowski T
    Transplantation; 2002 Sep; 74(6):892-5. PubMed ID: 12364876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 1990s perspective of hepatitis C, human immunodeficiency virus, and tuberculosis infections in dialysis patients.
    Murthy BV; Pereira BJ
    Semin Nephrol; 1997 Jul; 17(4):346-63. PubMed ID: 9241719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period.
    Jahng AW; Tran T; Bui L; Joyner JL
    Transplantation; 2007 Jun; 83(12):1557-62. PubMed ID: 17589337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.
    Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE
    Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoniazid-related hepatic failure in children: a survey of liver transplantation centers.
    Wu SS; Chao CS; Vargas JH; Sharp HL; Martín MG; McDiarmid SV; Sinatra FR; Ament ME
    Transplantation; 2007 Jul; 84(2):173-9. PubMed ID: 17667808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenge of tuberculosis in renal transplantation.
    Malhotra KK
    Transplant Proc; 2007 Apr; 39(3):756-8. PubMed ID: 17445591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The benefits of isoniazid chemoprophylaxis and risk factors for tuberculosis among Oglala Sioux Indians.
    Mori MA; Leonardson G; Welty TK
    Arch Intern Med; 1992 Mar; 152(3):547-50. PubMed ID: 1546917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance dialysis in patients from developing countries: the experience of an Italian center.
    Fogazzi GB; Castelnovo C
    J Nephrol; 2004; 17(4):552-8. PubMed ID: 15372418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal replacement therapy for diabetic end-stage renal disease. Experience of a Tunisian hospital centre.
    Abderrahim E; Zouaghi K; Hedri H; Ben Abdallah T; Ben Hamida F; Kaaroud H; Goucha R; Ben Abdallah N; Khiari K; El Younsi F; Ben Moussa F; Kheder A; Ben Maïz H
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):584-90. PubMed ID: 11694858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculosis in renal transplant recipients: a Brazilian center registry.
    Guida JP; Bignotto Rosane D; Urbini-Santos C; Alves-Filho G; Ribeiro Resende M; Mazzali M
    Transplant Proc; 2009 Apr; 41(3):883-4. PubMed ID: 19376379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of isoniazid prophylaxis in renal transplant recipients in a high tuberculosis burden country.
    Dodani SK; Nasim A; Aziz T; Naqvi A
    Transpl Infect Dis; 2021 Oct; 23(5):e13709. PubMed ID: 34331355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium tuberculosis infection following renal transplantation in Taiwan.
    Chen CH; Lian JD; Cheng CH; Wu MJ; Lee WC; Shu KH
    Transpl Infect Dis; 2006 Sep; 8(3):148-56. PubMed ID: 16913973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The specific features of the detection, clinical manifestations, and treatment of tuberculosis in the HIV-infected].
    Erokhin VV; Kornilova ZKh; Alekseeva LP
    Probl Tuberk Bolezn Legk; 2005; (10):20-8. PubMed ID: 16318255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoniazid hepatotoxicity among drug users: the role of hepatitis C.
    Fernández-Villar A; Sopeña B; Vázquez R; Ulloa F; Fluiters E; Mosteiro M; Martínez-Vázquez C; Piñeiro L
    Clin Infect Dis; 2003 Feb; 36(3):293-8. PubMed ID: 12539070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal hemorrhagic intracranial TB in a renal transplant recipient despite INH prophylaxis.
    Abutaleb N; Obaideen A; Hamza A; Zakaria M; Afifi H; Fallata S; Younis S; Adem M
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):594-8. PubMed ID: 17951949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.